Literature DB >> 18648628

Low-LET-induced radioprotective mechanisms within a stochastic two-stage cancer model.

H Schöllnberger1, R D Stewart, R E J Mitchel.   

Abstract

A stochastic two-stage cancer model with clonal expansion was used to investigate the potential impact on human lung cancer incidence of some aspects of the hormesis mechanisms suggested by Feinendegen (Health Phys. 52 663-669, 1987). The model was applied to low doses of low-LET radiation delivered at low dose rates. Non-linear responses arise in the model because radiologically induced adaptations in radical scavenging and DNA repair may reduce the biological consequences of DNA damage formed by endogenous processes and ionizing radiation. Sensitivity studies were conducted to identify critical model inputs and to help define the changes in cellular defense mechanisms necessary to produce a lifetime probability for lung cancer that deviates from a linear no-threshold (LNT) type of response. Our studies suggest that lung cancer risk predictions may be very sensitive to the induction of DNA damage by endogenous processes. For doses comparable to background radiation levels, endogenous DNA damage may account for as much as 50 to 80% of the predicted lung cancers. For an additional lifetime dose of 1 Gy from low-LET radiation, endogenous processes may still account for as much as 20% of the predicted cancers (Fig. 2). When both repair and scavengers are considered as inducible, radiation must enhance DNA repair and radical scavenging in excess of 30 to 40% of the baseline values to produce lifetime probabilities for lung cancer outside the range expected for endogenous processes and background radiation.

Entities:  

Keywords:  LNT; endogenous damage; hormesis; low-LET; lung cancer; radioprotective mechanisms; threshold

Year:  2006        PMID: 18648628      PMCID: PMC2477198          DOI: 10.2203/dose-response.003.04.006

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  47 in total

1.  Toxicology rethinks its central belief.

Authors:  Edward J Calabrese; Linda A Baldwin
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

2.  Bystander-induced apoptosis and premature differentiation in primary urothelial explants after charged particle microbeam irradiation.

Authors:  O V Belyakov; M Folkard; C Mothersill; K M Prise; B D Michael
Journal:  Radiat Prot Dosimetry       Date:  2002       Impact factor: 0.972

3.  Dose responses for adaption to low doses of (60)Co gamma rays and (3)H beta particles in normal human fibroblasts.

Authors:  E J Broome; D L Brown; R E J Mitchel
Journal:  Radiat Res       Date:  2002-08       Impact factor: 2.841

4.  Inducible repair of thymine glycol detected by an ultrasensitive assay for DNA damage.

Authors:  X C Le; J Z Xing; J Lee; S A Leadon; M Weinfeld
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

Review 5.  Two-event model for carcinogenesis: biological, mathematical, and statistical considerations.

Authors:  S H Moolgavkar; G Luebeck
Journal:  Risk Anal       Date:  1990-06       Impact factor: 4.000

Review 6.  Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis.

Authors:  G Bauer
Journal:  Histol Histopathol       Date:  1996-01       Impact factor: 2.303

7.  Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses.

Authors:  Kai Rothkamm; Markus Löbrich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

8.  Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll.

Authors:  M P Little
Journal:  Biometrics       Date:  1995-12       Impact factor: 2.571

9.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

Authors:  D L Preston; S Kusumi; M Tomonaga; S Izumi; E Ron; A Kuramoto; N Kamada; H Dohy; T Matsuo; T ] Matsui T [corrected to Matsuo
Journal:  Radiat Res       Date:  1994-02       Impact factor: 2.841

10.  Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Authors:  David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

View more
  7 in total

Review 1.  Systems biology and its potential role in radiobiology.

Authors:  Ludwig Feinendegen; Philip Hahnfeldt; Eric E Schadt; Michael Stumpf; Eberhard O Voit
Journal:  Radiat Environ Biophys       Date:  2007-12-18       Impact factor: 1.925

2.  A perspective on the scientific, philosophical, and policy dimensions of hormesis.

Authors:  George R Hoffmann
Journal:  Dose Response       Date:  2009-01-19       Impact factor: 2.658

3.  Protective bystander effects simulated with the state-vector model.

Authors:  Helmut Schöllnberger; Peter M Eckl
Journal:  Dose Response       Date:  2007-06-26       Impact factor: 2.658

4.  Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors.

Authors:  H Schöllnberger; J C Kaiser; P Jacob; L Walsh
Journal:  Radiat Environ Biophys       Date:  2012-03-22       Impact factor: 1.925

5.  Low-dose cancer risk modeling must recognize up-regulation of protection.

Authors:  Ludwig E Feinendegen; Myron Pollycove; Ronald D Neumann
Journal:  Dose Response       Date:  2009-12-10       Impact factor: 2.658

6.  Detrimental and protective bystander effects: a model approach.

Authors:  H Schöllnberger; R E J Mitchel; J L Redpath; D J Crawford-Brown; W Hofmann
Journal:  Radiat Res       Date:  2007-11       Impact factor: 2.841

7.  A model for low dose effects of low-LET radiation delivered at high dose rates.

Authors:  H Schöllnberger; R D Stewart; R E J Mitchel
Journal:  Int J Low Radiat       Date:  2006
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.